Microbiota-Based Drug Discovery
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
32
NCT05818306
A Phase Ia Safety and Tolerability Study of BL-001
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 20, 2023
Completion: Jun 2, 2023
Loading map...